Extracts from Stevia rebaudiana Bertoni, a plant native to Central and South America, have been used as a sweetener since ancient times. Currently, Stevia extracts are largely used as a noncaloric high-potency biosweetener alternative to sugar, due to the growing incidence of type 2 diabetes mellitus, obesity, and metabolic disorders worldwide. Despite the large number of studies on Stevia and steviol glycosides in vivo, little is reported concerning the cellular and molecular mechanisms underpinning the beneficial effects on human health. The effect of four commercial Stevia extracts on glucose transport activity was evaluated in HL-60 human leukaemia and in SH-SY5Y human neuroblastoma cells. The extracts were able to enhance glucose uptake in both cellular lines, as efficiently as insulin. Our data suggest that steviol glycosides could act by modulating GLUT translocation through the PI3K/Akt pathway since treatments with both insulin and Stevia extracts increased the phosphorylation of PI3K and Akt. Furthermore, Stevia extracts were able to revert the effect of the reduction of glucose uptake caused by methylglyoxal, an inhibitor of the insulin receptor/PI3K/Akt pathway. These results corroborate the hypothesis that Stevia extracts could mimic insulin effects modulating PI3K/Akt pathway (1).
Studies have shown that steviol glycosides are not teratogenic, mutagenic or carcinogenic and this study provides a summary of the biological and pharmacological properties of steviol glycosides that could be relevant for the treatment of human diseases (2).
References_____________________________________
(1) Steviol glycosides modulate glucose transport in different cell types.
Rizzo B, Zambonin L, Angeloni C, Leoncini E, Dalla Sega FV, Prata C, Fiorentini D, Hrelia S.
Oxid Med Cell Longev. 2013;2013:348169. doi: 10.1155/2013/348169.
(2) A Review on the pharmacology and toxicology of steviol glycosides extracted from Stevia rebaudiana.
Momtazi-Borojeni AA, Esmaeili SA, Abdollahi E, Sahebkar A.
Curr Pharm Des. 2016 Oct 21
